EDGAR Filing Documents for 0000899243-22-035055

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0000899243-22-035055

Filing Date

2022-11-03

Accepted

2022-11-03 21:12:13

Documents

Period of Report

2022-11-01

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 4 SUBMISSION	doc4.html	4
1	FORM 4 SUBMISSION	doc4.xml	4	3456
	Complete submission text file	0000899243-22-035055.txt		5252

Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121

Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500

LIGAND PHARMACEUTICALS INC (Reporting) CIK: 0000886163 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-56427 | Film No.: 221359921
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5980 HORTON STREET SUITE 600 EMERYVILLE CA 94608

Business Address 5980 HORTON STREET SUITE 600 EMERYVILLE CA 94608 858-652-1292

OmniAb Operations, Inc. (Issuer) CIK: 0001893653 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research